Neuroblastoma: A 20-year experience in a UK regional centre

Pediatric Blood and Cancer

Volumn 57, Issue 7, 2011, Pages 1254-1260

  Salim, Adeline ^a   Mullassery, Dhanya ^a   Pizer, Barry ^b   McDowell, Heather P ^b   Losty, Paul D ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Clinical outcomes; Neuroblastoma; Surgery; Survival

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CASE REPORT; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; HUMAN; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; MYCN GENE; NEUROBLASTOMA; ONCOGENE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TUMOR BIOPSY; UNITED KINGDOM;

ANTINEOPLASTIC AGENTS; CANCER CARE FACILITIES; CHEMOTHERAPY, ADJUVANT; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; GREAT BRITAIN; HUMANS; INFANT; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; MALE; NEOPLASM STAGING; NEUROBLASTOMA; NEUROSURGICAL PROCEDURES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80053907959     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23149     Document Type: Article

References (26)

1. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999;341:1165-1173.
2. Maris JM. Recent advances in neuroblastoma. N Engl J Med 2010;362:2202-2211.
3. La Quaglia MP. Surgical management of neuroblastoma. Semin Pediatr Surg 2001;10:132-139.
4. Tsuchida Y, Kaneko M. Surgery in pediatric solid tumors with special reference to advanced neuroblastoma. Acta Paediatr Taiwan 2002;43:67-71.
5. Castel V, Tovar JA, Costa E, et al. The role of surgery in stage IV neuroblastoma. J Pediatr Surg 2002;37:1574-1578.
6. von Schweinitz D, Hero B, Berthold F. The impact of surgical radicality on outcome in childhood neuroblastoma. Eur J Pediatr Surg 2002;12:402-409.
7. Adkins ES, Sawin R, Gerbing RB, et al. Efficacy of complete resection for high-risk neuroblastoma: A Children's Cancer Group study. J Pediatr Surg 2004;39:931-936.
8. Baker DL, Schmidt ML, Cohn SL, et al. Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. N Engl J Med 2010;363:1313-1323.
9. Lau L. Neuroblastoma: A single institution's experience with 128 children and an evaluation of clinical and biological prognostic factors. Pediatr Hematol Oncol 2002;19:79-89.
10. Bown N, Lastowska M, Cotterill S, et al. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group. Med Pediatr Oncol 2001;36:14-19.
11. Evans AE, D'Angio GJ, Randolph J. A proposed staging for children with neuroblastoma. Children's cancer study group A. Cancer 1971;27:374-378.
12. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11:1466-1477.
13. Yu AL, Gilman AL, Ozkaynak MF, et al. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med 363:1324-1334.
14. Di Cataldo A, Dau D, Conte M, et al. Diagnostic and prognostic markers in infants with disseminated neuroblastoma: A retrospective analysis from the Italian Cooperative Group for Neuroblastoma. Med Sci Monit 2009;15:MT11-MT18.
15. Canete A, Gerrard M, Rubie H, et al. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: The International Society of Paediatric Oncology European Neuroblastoma Experience. J Clin Oncol 2009;27:1014-1019.
16. Cecchetto G, Mosseri V, De Bernardi B, et al. Surgical risk factors in primary surgery for localized neuroblastoma: The LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J Clin Oncol 2005;23:8483-8489.
17. Davidoff AM, Corey BL, Hoffer FA, et al. Radiographic assessment of resectability of locoregional disease in children with high-risk neuroblastoma during neoadjuvant chemotherapy. Pediatr Blood Cancer 2005;44:158-162.
18. Simon T, Hero B, Benz-Bohm G, et al. Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial. Pediatr Blood Cancer 2008;50:965-969.
19. La Quaglia MP, Kushner BH, Su W, et al. The impact of gross total resection on local control and survival in high-risk neuroblastoma. J Pediatr Surg 2004;39:412-417;; discussion 412-417.
20. Losty P, Quinn F, Breatnach F, et al. Neuroblastoma-A surgical perspective. Eur J Surg Oncol 1993;19:33-36.
21. von Allmen D, Grupp S, Diller L, et al. Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant. J Pediatr Surg 2005;40:936-941;; discussion 941.
22. Kiely E. A technique for excision of abdominal and pelvic neuroblastomas. Ann R Coll Surg Engl 2007;89:342-348.
23. Kubota M, Yagi M, Kanada S, et al. Long-term follow-up status of patients with neuroblastoma after undergoing either aggressive surgery or chemotherapy-A single institutional study. J Pediatr Surg 2004;39:1328-1332.
24. Cheung NK, Kushner BH, LaQuaglia M, et al. N7: A novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age. Med Pediatr Oncol 2001;36:227-230.
25. Kushner BH, Kramer K, Cheung NK. Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma. J Clin Oncol 2001;19:4189-4194.
26. Fish JD, Grupp SA. Stem cell transplantation for neuroblastoma. Bone Marrow Transplant 2008;41:159-165.